英聯股份(002846.SZ):擬分階段向揚州英聯增資3億元
格隆匯12月23日丨英聯股份(002846.SZ)公佈,公司於2021年12月22日召開的第三屆董事會第十七次會議和第三屆監事會第十六次會議審議通過了《關於向控股子公司英聯金屬科技(揚州)有限公司增資的議案》,同意公司分階段、依子公司實際需求向控股子公司英聯金屬科技(揚州)有限公司(“揚州英聯”)增資3億元人民幣,全部增資後揚州英聯的註冊資本將由現在的2億元人民幣增加至5億元人民幣。此次增資前,公司持有揚州英聯95%股份,揚州英聯為公司控股子公司;增資全部完成後,公司將持有揚州英聯98%股份,其仍為公司控股子公司。該事項尚需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.